-
Orelabrutinib Testing in RRMS Phase 2 Trial Set to Launch by InnoCare
InnoCare Pharma is set to launch a Phase 2 trial to test orelabrutinib in patients with relapsing-remitting multiple sclerosis. Click here to learn more.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.